Ieq Capital, LLC Biomarin Pharmaceutical Inc Transaction History
Ieq Capital, LLC
- $10.1 Billion
- Q4 2024
A detailed history of Ieq Capital, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Ieq Capital, LLC holds 60,287 shares of BMRN stock, worth $3.85 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
60,287
Previous 7,136
744.83%
Holding current value
$3.85 Million
Previous $501,000
690.82%
% of portfolio
0.04%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding BMRN
# of Institutions
645Shares Held
179MCall Options Held
2MPut Options Held
1.28M-
Black Rock Inc. New York, NY22.7MShares$1.45 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.23 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.21 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$889 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$671 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.9B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...